{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:36:31Z","timestamp":1747204591576,"version":"3.40.5"},"posted":{"date-parts":[[2023,4,20]]},"group-title":"In Review","reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,3,24]]},"abstract":"<title>Abstract<\/title>\n        <p>Invasion of human red blood cells (RBCs) by <italic>Plasmodium falciparum<\/italic> (Pf) merozoites relies on the interaction between two parasite proteins, apical membrane antigen 1 (AMA1) and rhoptry neck protein 2 (RON2)<sup>1,2<\/sup>. Antibodies to AMA1 confer limited protection against <italic>P. falciparum<\/italic> in non-human primate malaria models<sup>3,4<\/sup>. However, clinical trials with recombinant AMA1 alone (apoAMA1) saw no protection, likely due to inadequate levels of functional antibodies<sup>5\u20138<\/sup>. Notably, immunization with AMA1 in its ligand bound conformation using RON2L, a 49 amino acid peptide from RON2, confers superior protection against <italic>P. falciparum<\/italic> malaria by enhancing the proportion of neutralizing antibodies<sup>9,10<\/sup>. A limitation of this approach, however, is that it requires the two vaccine components to form a complex in solution. To facilitate vaccine development, we engineered chimeric antigens by strategically replacing the AMA1 DII loop that is displaced upon ligand binding with RON2L. Structural characterization of the fusion chimera, Fusion-F<sub>D12<\/sub> to 1.55 \u00c5 resolution showed that it closely mimics the binary receptor-ligand complex. Immunization studies showed that Fusion-F<sub>D12<\/sub> immune sera neutralized parasites more efficiently than apoAMA1 immune sera despite having an overall lower anti-AMA1 titer, suggesting improvement in antibody quality. Furthermore, immunization with Fusion-F<sub>D12<\/sub> enhanced antibodies targeting conserved epitopes on AMA1 resulting in greater neutralization of non-vaccine type parasites. Identifying epitopes of such cross-neutralizing antibodies will help in the development of an effective, strain-transcending malaria vaccine. Our fusion protein design is a robust vaccine platform that can be enhanced by incorporating polymorphisms in AMA1 to effectively neutralize all <italic>P. falciparum<\/italic> parasites.<\/p>","DOI":"10.21203\/rs.3.rs-2733434\/v1","type":"posted-content","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T18:17:23Z","timestamp":1682014643000},"source":"Crossref","is-referenced-by-count":0,"title":["Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies"],"prefix":"10.21203","author":[{"given":"Prakash","family":"Sriniva","sequence":"first","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Yanik","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Venkatesh","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Parker","sequence":"additional","affiliation":[{"name":"University of Victoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ababacar","family":"Diouf","sequence":"additional","affiliation":[{"name":"NIAID, NIH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-2432","authenticated-orcid":false,"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Long","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria and Vector Resarch, NIAID\/NIH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Boulanger","sequence":"additional","affiliation":[{"name":"University of Victoria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1074\/jbc.M109.080770","article-title":"Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites","volume":"285","author":"Richard D","year":"2010","unstructured":"Richard, D. et al. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J Biol Chem 285, 14815\u201314822 (2010). https:\/\/doi.org:10.1074\/jbc.M109.080770","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1073\/pnas.1110303108","article-title":"Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion","volume":"108","author":"Srinivasan P","year":"2011","unstructured":"Srinivasan, P. et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci U S A 108, 13275\u201313280 (2011). https:\/\/doi.org:10.1073\/pnas.1110303108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1128\/IAI.70.12.6961-6967.2002","article-title":"Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria","volume":"70","author":"Stowers AW","year":"2002","unstructured":"Stowers, A. W. et al. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect Immun 70, 6961\u20136967 (2002). https:\/\/doi.org:10.1128\/IAI.70.12.6961-6967.2002","journal-title":"Infect Immun"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e8138","DOI":"10.1371\/journal.pone.0008138","article-title":"High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model","volume":"4","author":"Dutta S","year":"2009","unstructured":"Dutta, S. et al. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model. PLoS One 4, e8138 (2009). https:\/\/doi.org:10.1371\/journal.pone.0008138","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e5254","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A","volume":"4","author":"Spring MD","year":"2009","unstructured":"Spring, M. D. et al. Phase 1\/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One 4, e5254 (2009). https:\/\/doi.org:10.1371\/journal.pone.0005254","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1475-2875-9-175","article-title":"Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine","volume":"9","author":"Ouattara A","year":"2010","unstructured":"Ouattara, A. et al. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar J 9, 175 (2010). https:\/\/doi.org:10.1186\/1475-2875-9-175","journal-title":"Malar J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12936-016-1466-4","article-title":"Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25\u2013545]) in healthy Malian adults in Bandiagara","volume":"15","author":"Thera MA","year":"2016","unstructured":"Thera, M. A. et al. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25\u2013545]) in healthy Malian adults in Bandiagara. Malar J 15, 442 (2016). https:\/\/doi.org:10.1186\/s12936-016-1466-4","journal-title":"Malar J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/infdis\/jiw039","article-title":"Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1\/AS01","volume":"213","author":"Payne RO","year":"2016","unstructured":"Payne, R. O. et al. Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1\/AS01. J Infect Dis 213, 1743\u20131751 (2016). https:\/\/doi.org:10.1093\/infdis\/jiw039","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"10311","DOI":"10.1073\/pnas.1409928111","article-title":"Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria","volume":"111","author":"Srinivasan P","year":"2014","unstructured":"Srinivasan, P. et al. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria. Proc Natl Acad Sci U S A 111, 10311\u201310316 (2014). https:\/\/doi.org:10.1073\/pnas.1409928111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0015-7","article-title":"A malaria vaccine protects","volume":"2","author":"Srinivasan P","year":"2017","unstructured":"Srinivasan, P. et al. A malaria vaccine protects. NPJ Vaccines 2 (2017). https:\/\/doi.org:10.1038\/s41541-017-0015-7","journal-title":"NPJ Vaccines"},{"key":"ref11","volume-title":"World malaria report","author":"WHO","year":"2021","unstructured":"WHO. World malaria report. (World Health Organization, 2021)."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Rts SCTP","year":"2015","unstructured":"Rts, S. C. T. P. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015). https:\/\/doi.org:10.1016\/S0140-6736(15)60721-8","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102193","DOI":"10.1016\/j.mib.2022.102193","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies","volume":"69","author":"Ward KE","year":"2022","unstructured":"Ward, K. E., Fidock, D. A. & Bridgford, J. L. Plasmodium falciparum resistance to artemisinin-based combination therapies. Curr Opin Microbiol 69, 102193 (2022). https:\/\/doi.org:10.1016\/j.mib.2022.102193","journal-title":"Curr Opin Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ni.f.205","article-title":"Immunity to malaria: more questions than answers","volume":"9","author":"Langhorne J","year":"2008","unstructured":"Langhorne, J., Ndungu, F. M., Sponaas, A. M. & Marsh, K. Immunity to malaria: more questions than answers. Nat Immunol 9, 725\u2013732 (2008). https:\/\/doi.org:10.1038\/ni.f.205","journal-title":"Nat Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1046\/j.1365-2958.2000.02175.x","article-title":"Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species","volume":"38","author":"Triglia T","year":"2000","unstructured":"Triglia, T. et al. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol 38, 706\u2013718 (2000). https:\/\/doi.org:10.1046\/j.1365-2958.2000.02175.x","journal-title":"Mol Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","article-title":"Specificity of the protective antibody response to apical membrane antigen 1","volume":"69","author":"Hodder AN","year":"2001","unstructured":"Hodder, A. N., Crewther, P. E. & Anders, R. F. Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 69, 3286\u20133294 (2001). https:\/\/doi.org:10.1128\/IAI.69.5.3286-3294.2001","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cmi.12287","article-title":"Conditional expression of apical membrane antigen 1 in Plasmodium falciparum shows it is required for erythrocyte invasion by merozoites","volume":"16","author":"Yap A","year":"2014","unstructured":"Yap, A. et al. Conditional expression of apical membrane antigen 1 in Plasmodium falciparum shows it is required for erythrocyte invasion by merozoites. Cell Microbiol 16, 642\u2013656 (2014). https:\/\/doi.org:10.1111\/cmi.12287","journal-title":"Cell Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e1010643","DOI":"10.1371\/journal.ppat.1010643","article-title":"The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts","volume":"18","author":"Fernandes P","year":"2022","unstructured":"Fernandes, P. et al. The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. PLoS Pathog 18, e1010643 (2022). https:\/\/doi.org:10.1371\/journal.ppat.1010643","journal-title":"PLoS Pathog"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/IAI.74.5.2628-2636.2006","article-title":"The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody","volume":"74","author":"Coley AM","year":"2006","unstructured":"Coley, A. M. et al. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect Immun 74, 2628\u20132636 (2006). https:\/\/doi.org:10.1128\/IAI.74.5.2628-2636.2006","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"12736","DOI":"10.1073\/pnas.0501808102","article-title":"Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket","volume":"102","author":"Bai T","year":"2005","unstructured":"Bai, T. et al. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci U S A 102, 12736\u201312741 (2005). https:\/\/doi.org:10.1073\/pnas.0501808102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e70637","DOI":"10.1371\/journal.pone.0070637","article-title":"Toxoplasma gondii sporozoites invade host cells using two novel paralogues of RON2 and AMA1","volume":"8","author":"Poukchanski A","year":"2013","unstructured":"Poukchanski, A. et al. Toxoplasma gondii sporozoites invade host cells using two novel paralogues of RON2 and AMA1. PLoS One 8, e70637 (2013). https:\/\/doi.org:10.1371\/journal.pone.0070637","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1002755","DOI":"10.1371\/journal.ppat.1002755","article-title":"Structural and functional insights into the malaria parasite moving junction complex","volume":"8","author":"Normand Vulliez-Le","year":"2012","unstructured":"Vulliez-Le Normand, B. et al. Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog 8, e1002755 (2012). https:\/\/doi.org:10.1371\/journal.ppat.1002755","journal-title":"PLoS Pathog"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e1003840","DOI":"10.1371\/journal.ppat.1003840","article-title":"Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1","volume":"9","author":"Dutta S","year":"2013","unstructured":"Dutta, S. et al. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. PLoS Pathog 9, e1003840 (2013). https:\/\/doi.org:10.1371\/journal.ppat.1003840","journal-title":"PLoS Pathog"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1128\/IAI.71.8.4749-4758.2003","article-title":"Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1","volume":"71","author":"Mueller MS","year":"2003","unstructured":"Mueller, M. S. et al. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect Immun 71, 4749\u20134758 (2003). https:\/\/doi.org:10.1128\/IAI.71.8.4749-4758.2003","journal-title":"Infect Immun"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1074\/jbc.M610562200","article-title":"Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1","volume":"282","author":"Collins CR","year":"2007","unstructured":"Collins, C. R. et al. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J Biol Chem 282, 7431\u20137441 (2007). https:\/\/doi.org:10.1074\/jbc.M610562200","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1248\/yakushi.131.1733","article-title":"MF59 adjuvanted seasonal and pandemic influenza vaccines","volume":"131","author":"Tsai TF","year":"2011","unstructured":"Tsai, T. F. MF59 adjuvanted seasonal and pandemic influenza vaccines. Yakugaku Zasshi 131, 1733\u20131741 (2011). https:\/\/doi.org:10.1248\/yakushi.131.1733","journal-title":"Yakugaku Zasshi"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1365-2958.2003.03974.x","article-title":"Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum","volume":"52","author":"Healer J","year":"2004","unstructured":"Healer, J. et al. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol Microbiol 52, 159\u2013168 (2004). https:\/\/doi.org:10.1111\/j.1365-2958.2003.03974.x","journal-title":"Mol Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper CM","year":"1987","unstructured":"Snapper, C. M. & Paul, W. E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944\u2013947 (1987). https:\/\/doi.org:10.1126\/science.3107127","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200901","article-title":"Plasmodium falciparum-specific IgM B cells dominate in children, expand with malaria, and produce functional IgM","volume":"218","author":"Hopp CS","year":"2021","unstructured":"Hopp, C. S. et al. Plasmodium falciparum-specific IgM B cells dominate in children, expand with malaria, and produce functional IgM. J Exp Med 218 (2021). https:\/\/doi.org:10.1084\/jem.20200901","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/cid\/cit174","article-title":"An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection","volume":"57","author":"Tran TM","year":"2013","unstructured":"Tran, T. M. et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis 57, 40\u201347 (2013). https:\/\/doi.org:10.1093\/cid\/cit174","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen S","year":"1961","unstructured":"Cohen, S., Mc, G. I. & Carrington, S. Gamma-globulin and acquired immunity to human malaria. Nature 192, 733\u2013737 (1961). https:\/\/doi.org:10.1038\/192733a0","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1016\/j.vaccine.2015.09.093","article-title":"Recent advances in recombinant protein-based malaria vaccines","volume":"33","author":"Draper SJ","year":"2015","unstructured":"Draper, S. J. et al. Recent advances in recombinant protein-based malaria vaccines. Vaccine 33, 7433\u20137443 (2015). https:\/\/doi.org:10.1016\/j.vaccine.2015.09.093","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2219533120","DOI":"10.1073\/pnas.2219533120","article-title":"Invasion of Toxoplasma gondii bradyzoites: Molecular dissection of the moving junction proteins and effective vaccination targets","volume":"120","author":"Najm R","year":"2023","unstructured":"Najm, R. et al. Invasion of Toxoplasma gondii bradyzoites: Molecular dissection of the moving junction proteins and effective vaccination targets. Proc Natl Acad Sci U S A 120, e2219533120 (2023). https:\/\/doi.org:10.1073\/pnas.2219533120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41564-022-01261-2","article-title":"PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","author":"Scally SW","year":"2022","unstructured":"Scally, S. W. et al. PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum. Nat Microbiol 7, 2039\u20132053 (2022). https:\/\/doi.org:10.1038\/s41564-022-01261-2","journal-title":"Nat Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies","volume":"178","author":"Alanine DGW","year":"2019","unstructured":"Alanine, D. G. W. et al. Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies. Cell 178, 216\u2013228.e221 (2019). https:\/\/doi.org:10.1016\/j.cell.2019.05.025","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"15644","DOI":"10.1074\/jbc.M109.092619","article-title":"Structural characterization of apical membrane antigen 1 (AMA1) from Toxoplasma gondii","volume":"285","author":"Crawford J","year":"2010","unstructured":"Crawford, J., Tonkin, M. L., Grujic, O. & Boulanger, M. J. Structural characterization of apical membrane antigen 1 (AMA1) from Toxoplasma gondii. J Biol Chem 285, 15644\u201315652 (2010). https:\/\/doi.org:10.1074\/jbc.M109.092619","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/pro.2193","article-title":"Babesia divergens and Neospora caninum apical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasion","volume":"22","author":"Tonkin ML","year":"2013","unstructured":"Tonkin, M. L., Crawford, J., Lebrun, M. L. & Boulanger, M. J. Babesia divergens and Neospora caninum apical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasion. Protein Sci 22, 114\u2013127 (2013). https:\/\/doi.org:10.1002\/pro.2193","journal-title":"Protein Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1128\/IAI.70.12.6948-6960.2002","article-title":"In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response","volume":"70","author":"Kennedy MC","year":"2002","unstructured":"Kennedy, M. C. et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun 70, 6948\u20136960 (2002). https:\/\/doi.org:10.1128\/IAI.70.12.6948-6960.2002","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"Battye TG","year":"2011","unstructured":"Battye, T. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr 67, 271\u2013281 (2011). https:\/\/doi.org:10.1107\/S0907444910048675","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"Evans P","year":"2006","unstructured":"Evans, P. Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62, 72\u201382 (2006). https:\/\/doi.org:10.1107\/S0907444905036693","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn MD","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235\u2013242 (2011). https:\/\/doi.org:10.1107\/S0907444910045749","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1107\/S0907444906045975","article-title":"Solving structures of protein complexes by molecular replacement with Phaser","volume":"63","author":"McCoy AJ","year":"2007","unstructured":"McCoy, A. J. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr D Biol Crystallogr 63, 32\u201341 (2007). https:\/\/doi.org:10.1107\/S0907444906045975","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley P","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486\u2013501 (2010). https:\/\/doi.org:10.1107\/S0907444910007493","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine PV","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr 68, 352\u2013367 (2012). https:\/\/doi.org:10.1107\/S0907444912001308","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen VB","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66, 12\u201321 (2010). https:\/\/doi.org:10.1107\/S0907444909042073","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/elps.202000365","article-title":"Characterization of AMA1-RON2L complex with native gel electrophoresis and capillary isoelectric focusing","volume":"43","author":"Zhu D","year":"2022","unstructured":"Zhu, D. et al. Characterization of AMA1-RON2L complex with native gel electrophoresis and capillary isoelectric focusing. Electrophoresis 43, 509\u2013515 (2022). https:\/\/doi.org:10.1002\/elps.202000365","journal-title":"Electrophoresis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura K","year":"2008","unstructured":"Miura, K. et al. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 26, 193\u2013200 (2008). https:\/\/doi.org:10.1016\/j.vaccine.2007.10.064","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/273621a0","article-title":"Cultivation of malarial parasites","volume":"273","author":"Trager W","year":"1978","unstructured":"Trager, W. & Jenson, J. B. Cultivation of malarial parasites. Nature 273, 621\u2013622 (1978). https:\/\/doi.org:10.1038\/273621a0","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"Malkin EM","year":"2005","unstructured":"Malkin, E. M. et al. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun 73, 3677\u20133685 (2005). https:\/\/doi.org:10.1128\/IAI.73.6.3677-3685.2005","journal-title":"Infect Immun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2733434\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2733434\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T16:57:11Z","timestamp":1696006631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2733434\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":49,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2733434\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-023-41636-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,4,20]]},"subtype":"preprint"}}